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1. Introduction
   Diabetes is a major disease about 10% of the total population 
which is caused by a metabolic disorder characterized by fast 
elevation of blood sugar level. Due to introduction of hypoglycemic 
agents, diabetes and the related complications continue to be a major 
medical problem[1]. It is estimated 171 million people suffering 
from diabetes in 2000 and possibility to increase this value up to 
366 million in 2030. In addition, diarrhoeal diseases are one of the 
leading causes of morbidity and mortality in developing countries 
and are responsible for the death of millions of people each year[2,3]. 
   It is reported that- approximately 80 percent of the populations 
in some Asian and African countries presently use herbal medicine 
for some aspect of primary health care. It also encouraged studies 
for the treatment and prevention of diabetes and diarrhoeal diseases 
depending on traditional medical practices[4,5]. 
   Guava [Psidium guajava (L.) Bat (P. guajava)] belonging to 
family Myrtaceae is a traditionally used plant because of its 
nutrition value. Guava is widely grown in tropical areas like India, 
Bangladesh, Florida, and West Indies. Different parts of guava are 
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Objective: To evaluate the antidiabetic and the antidiarrhoeal effects of ethanolic extracts of 
Psidium guajava leave (EEPGL) in Wister rats to support its traditional uses. 
Methods: Oral glucose tolerance test model and alloxan induced diabetic test model were 
performed to evaluate antidiabetic activity of EEPGL at doses of 1.00, 0.50 and 0.75 g/kg 
respectively. For antidiarrhoeal effects of EEPGL, castor oil-induced diarrhoea model and 
gastrointestinal motility test with barium sulphate milk model were also assessed at doses of 
750, 500 and 250 mg/kg, respectively. 
Results: Administration of EEPGL at doses 1.00 and 0.50 g/kg significantly (P<0.05) 
decreased blood glucose levels in oral glucose tolerance test model as well as 0.75 g/kg dose 
in alloxan induced diabetic test model in Wister rats (P<0.001). Application of EEPGL at doses 
of 750 and 500 mg/kg showed antidiarrhoeal effect in castor oil-induced diarrhoeal model 
(P<0.001 and P<0.01, respectively), and 750 mg/kg (P<0.01), 500 and 250 mg/kg (P<0.05) 
doses in barium sulphate milk model in aforesaid animals.
Conclusions: These results exhibited the significant antidiabetic and antidiarrhoeal activities 
of ethanolic extracts of Psidium guajava leave in Wister rats.
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reported to be used in folk medicine. In particular, the leaf extract 
of guava has traditionally been used for the treatment of diabetes in 
East Asia and other countries[6-8]. 
   P. guajava is also a relatively well-studied species with respect 
to diarrhoea[9,10]. In Bangladesh, tribes and traditional medicine 
practitioners use local plants for treatment of various diseases[11]. In 
addition, for millions who live in remote villages amid the constant 
risk of recurrent cholera and diarrhoea, the boiling of a few tender 
guava leaves, which are available in every household, together with 
rice powder, can be a life-saving solution for preventing cholera 
related death[2,12]. A few workers reported on guava plants under 
consideration of its medicinal and economic importance[13,14]. The 
aim of the present study is to evaluate of pharmacological effects on 
ethanolic guava leaf extract.
2. Materials and methods
2.1. Plant material and extraction
   P. guajava leaves were collected from the Chittagong University 
Campus, Chittagong, Bangladesh in August 2012. The plant was 
taxonomically identified by Professor Dr. Mostafa Kamal Pasha, 
Department of Botany, University of Chittagong and the voucher 
specimen (Pharma-0024/2012) was deposited at Pharmacological 
Research Division,  Bangladesh Council of Scientific and Industrial 
Research (BCSIR) Laboratories, Chittagong, Bangladesh. The 
collected leaves were washed, chopped, dried, powdered and 
extracted with 98% ethanol and concentrated by using rotary 
vacuum evaporator. The yield of the extract was 3.52% (w/w, in 
terms of dried starting material) which was kept in refrigerator at 
4 °C.
2.2. Experimental animals
   Male Wister rats weighting (180依10) g were procured from animal 
house of BCSIR Laboratories Chittagong to assess the antidiabetic 
and the antidiarrhoeal activity. All animals were kept under standard 
laboratory conditions. The animals were fed with standard diet 
and allowed to drink water ad libitum. All aspects of animal care 
complied with the ethical guidelines of Pharmacology Research 
Division, BCSIR Laboratories Chittagong, Bangladesh. 
2.3. Chemicals 
   All chemicals and drugs of this experiments such as castor-oil 
(Shengyang Kaiyingsheng Chemical Co. Ltd., China), Tween 80 
[Polyoxyethylene (20), Loba Chemie Pvt. Ltd., India], alloxan 
tetrahydrate (Merck, India), glibenclamide (Marion Roussel Ltd., 
Aventis, Bangladesh), loperamide (Opsonin, Bangladesh), glucose 
powder (dextrose monohydrate, GlaxoSmithKline, Chittagong, 
Bangladesh Ltd.), barium sulfate (BaSO4) (Merck, India Ltd.) and 
diethyl ether (Sigma-Aldrich, India) were obtained commercially 
and were of analytical grade.
2.4. Experiments
2.4.1. Oral glucose tolerance test (OGTT) model
   The OGTT was performed in overnight fasted (18 h) normal rats 
as per reported method[15]. Firstly, blood glucose level (BGL) of all 
fasted rats was withdrawn from the tip of tail and measured as “0 min” 
with the help of a blood glucose meter (Accu-Chek Active, Roche 
Diagnostics, Germany). Then, they were divided into four groups 
(n=5). Control animals received only distilled water (2 mL per rat) 
as Group I. Group II rats were given glibenclamide orally at a dose 
level 4.15 mg/kg body weight as positive control. Wister rats in 
Group III and IV were treated orally with EEPGL at doses of 1.0 and 
0.5 g/kg body weight, respectively. After 30 min, BGL of all groups 
was measured. Then these animals were given glucose solution 
(10 g/kg body weight) orally and the concentration of BGL was 
estimated at 30, 60, 120 min subsequently. 
2.4.2. Alloxan induced diabetic test model 
   After fasts of 18 h, forty two male Wister rats were induced by 
alloxan tetrahydrate (100 mg/kg i.p.) in sterile saline. Diabetes was 
confirmed after 24 h with BGL of >10 mmol/L. Then the diabetic 
animals were separated and used for the study. Fifteen diabetic 
rats were selected and randomly divided into three experimental 
groups (marked as Group II to IV). Each group contains five rats. 
Group II as diabetic control received only distilled water. Group 
III as positive control was treated antidiabetic drug glibenclamide 
(4.15 mg/kg). Group IV was treated with ethanolic extracts of 
P. guajava leave (EEPGL) at 750 mg/kg. Group I was previously 
selected as control group which was non diabetic. After extract/
drug administration, BGL of samples was determined at 0 h, 3 h, 
6 h and 9 h by aforesaid system. All the animals were anesthetized 
with diethyl ether during blood collection. Room temperature and 
humidity were maintained in order to increase the survival capacity 
of treated rats.
2.4.3. Castor oil-induced diarrhoea (COID) model
   To determine antidiarrhoeal activity of EEPGL, COID model was 
conducted by following described method[16]. Twenty five Wister 
rats were randomly divided into five equal groups (n=5) namely 
control group, positive control group and three treated groups. 
The control group received only distilled water 2 mL per rat while 
positive control group received loperamide 2 mg/kg as standard and 
three treated groups received EEPGL at the dose of 750 mg/kg, 
500 mg/kg and 2 50 mg/kg body weight, respectively. Rats were 
housed in separate cages with paper placed below for collection of 
fecal matters. Firstly, extract and drug were given orally to treated 
groups and positive control group respectively. In control group, 
only distill water was given orally. Then, one hour later castor oil 
(2 mL per rat) was induced orally to all rats initiating diarrhoea. 
The number of both hard and soft pellets was counted at every hour 
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over 6 h period for each rat. Diarrhoea was defined as the presence 
of stool with fluid material that stained the paper placed beneath the 
cages.
2.4.4. Gastrointestinal motility test with BaSO4 milk (BSM) 
model for diarrhoea
   BSM model was carried out by reported method[17]. Overnight 
fasted (18 h) twenty five Wister rats were randomly divided in to 
five equal groups (n=5). Control group received only distilled water 
2 mL per rat orally. Positive control group received commercially 
available anti diarrhoeal drug loperamide 2 mg/kg orally. Treated 
groups received EEPGL 250 mg/kg, 500 mg/kg and 750 mg/kg orally. 
After thirty minutes, all groups of rats were administered with 2 mL 
of 10% BaSO4 solution. Lastly, after 30 min rats were sacrificed. 
Finally, the distance traveled by BaSO4 milk was measured and 
expressed as a percentage of the total length of small intestine (from 
pylorus to the ileo-cecal junction).
2.5. Statistical analysis
   All the values of antidiarrhoeal, tests were expressed as mean依
SEM (standard error of the mean). Statistical differences between 
the mean of the various groups were analyzed by using student’s 
t test. All the graphical presentation and statistical calculations 
were prepared using “Microsoft Excel-2007”. Mean values were 
considered significantly different if P<0.05, P<0.01 and P<0.001. 
3. Results 
3.1. Effect of EEPGL on OGTT model
   The results of OGTT of positive control and different doses of 
EEPGL on Wister rats are shown in Table 1. All the doses of EEPGL 
and positive control were effective to the decreased BGL with 
increasing exposure time. Positive control exhibited the lowest 
BGL in all intervals, whereas among the different doses of EEPGL 
1 g/kg shown lower BGL at all intervals. The BGL in the positive 
control were 4.54, 3.60, 8.66, 6.42 and 2.88 mmol/L at different 
administrations shown in Table 1. From results significant (P<0.05) 
BGL reductions were at 1 g/kg and 0.5 g/kg doses of EEPGL. 
Table 1
Effect of EEPGL on oral glucose tolerance test.
Groups Blood glucose concentration (mmol/L)
Fasting Treatmenta Glucose administration
 0 min 30 min 30 min 60 min 120 min 
Group I 4.18±0.34 4.56±0.16 12.70±1.21 12.08±1.13 10.10±0.58
Group II 4.54±0.45 3.60±0.34* 8.66±0.58* 6.42±0.58** 2.88±0.34***
Group III 4.04±0.25 4.50±0.31 11.52±2.55 7.62±1.21* 4.86±1.12*
Group IV 4.50±0.30 5.10±0.27 11.88±2.40 9.50±2.33 7.10±0.90*
Values are expresed as mean±SEM. a: Group I was treated with stilled water, 
Group II with glibenclamide, Group III and IV with EEPGL at doses of 1.0 and 
0.5 g/kg body weight, respectively. *: P<0.05, **: P<0.01, ***: P<0.001 means 
significant difference compared control with positive control and extract.
3.2. Effect of EEPGL on alloxan induced diabetic test model
   The mean blood glucose concentration of control, diabetic control, 
positive control and plant extract on alloxan induced diabetic rats 
were estimated at 0, 3, 6 and 9 h, respectively as shown in Table 2. 
After the administration of alloxan, BGL increased. The mean BGL 
in the case of alloxan induced diabetic rats were 19.46, 22.72, 24.90 
and 29.03 mmol/L at the 0, 3, 6 and 9 h, respectively. After 3 h of the 
administration in Groups III and IV the BGL of treated rats gradually 
decreased shown in Table 2. Extracts of P. guajava and positive 
control had equally effective in reduction of BGL in alloxane induced 
diabetic rats (P<0.001 and P<0.01).
Table 2
Effect of EEPGL on alloxan induced model.
Test samples Mean of blood glucose concentration (mmol/L)
0 h 3 h 6 h 9 h
Group I 6.78±0.29 6.54±0.51 6.70±0.38 6.14±0.22
Group II    19.46±0.59###    22.72±0.99###   24.90±1.06###   29.03±1.81###
Group III 21.44±1.52 16.14±1.74    9.30±1.81**     5.36±0.59***
Group IV 21.52±0.63    18.80±0.82**    10.74±0.45***     7.22±0.53***
Values are expresed as mean±SEM; ###: P<0.001 means significant difference 
compared control with diabetic control. *: P<0.05, **: P<0.01 and ***: 
P<0.001 refer to diabetic control compared with positive control and extract. 
3.3. Effect of EEPGL on COID model
   The results about antidiarrhoeal effect of loperamide and EEPGL 
in COID on Wister albino rats are shown in Table 3. The results 
indicated that both P. guajava leaf extracts and loperamide inhibited 
significantly the frequency of defecation and wetted feces when 
compared to the control group and treated group (P<0.001 and 
P<0.01). 
Table 3
Effect of EEPGL on COID model.
Group Total faeces in 6 
h
% Inhibition 
of defecation
No. of wet 
faeces in 6 h
% Inhibition 
of defecation
Control 21.40依2.07 19.80依3.63
Positive control (loperamide)   5.20依0.84*** 76 2.60依0.89*** 87
Leaves 
extract
750 mg/kg     10.20依1.48*** 52  7.40依1.14*** 63
500 mg/kg    15.80依2.28** 26 11.20依1.48** 43
250 mg/kg  19.20依4.87 10 16.60依3.65 16
Values are expresed as mean依SEM; **: P<0.01 and ***: P<0.001 significant compared 
control with positive control and extract.
3.4. Effect of EEPGL on BSM model
   The results about gastrointestinal motility test with BSM of EEPGL 
and loperamide on Wister rats are shown Table 4. Both treated 
groups of P. guajava leaf extracts and loperamide significantly 
decreased the gastrointestinal motility of rats in BSM model at 30 
min study. In addition, percentages of inhibition in three treated 
groups compared to control group are 37.83%, 30.01% and 29.56% 
at doses of 750, 500 and 250 mg/kg, respectively, while positive 
control exhibits 39.60% inhibition.
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Table 4
Effect of EEPGL on gastrointestinal motility with BSM on rats.
Group Length of 
gastrointestinal 
tract (cm)
Distance  passed 
by BaSO4 cm
    (Mean±SEM)
BaSO4
transverse (%)
Inhibition
 (%)
Control 117.80±6.80 69.00±5.00 58.57
Positive control (loperamide) 113.70±4.50   40.20±12.10    35.38*** 39.60
P. guajava L. 750 mg/kg 115.20±7.02   41.60±13.59   36.41** 37.83
500 mg/kg 113.00±7.60   46.20±22.65  40.99* 30.01
250 mg/kg   111.00±12.47 45.80±9.02  41.26* 29.56
Values are expresed as mean±SEM; *: P<0.05, **: P<0.01 and ***: P<0.001 
refer to significant difference compared control with positive control and 
extract respectively.
4. Discussion
   The leaf extract of P. guajava stimulated glucose metabolic 
enzymes in liver tissues[6,19]. However, treatment with freshly 
prepared EEPGL significantly reduced BGL and lipid profile levels 
in diabetic albino rats and had similar effect in diabetic patients[20]. 
The results in this study revealed the antidiabetic activity of 
selected EEPGL which is significant at positive control (P<0.01 and 
P<0.001). The present study also supports most of the previous 
reports shown that guava leaf can decrease BGL[19,21-24]. Though the 
antidiabetic activity of EEPGL was diverse at different treated doses 
in the present study, it supported the folklore claim on antidiabetic 
activity of these plants[8].
   P. guajava leaf aqueous extract (50–400 mg/kg, p.o.) produced 
dose dependent and significant (P<0.05–0.01) protection of rats and 
mice against COID[25]. In the same model, the crude extract of P. 
guajava (100-1 000 mg/kg), provided 20.52%-81.05% protection, 
similar to loperamide[26]. 
   In the present study, the EEPGL was exhibited antidiarrhoeal effects 
in Waster rats. It was found to be significantly different at P<0.01 
and P<0.05 with respect to control. The crude extract provided 
protection from diarrhoea in COID, similar to loperamide, a standard 
antidiarrhoeal agent[27]. Some authors reported positively for P. 
guajava leaf extract in hyperactive gut disorders which has been 
supported by the present study[28,29]. In addition, it also reported 
that EEPGL protected diarrhoea up to level of 55.6%[2]. These results 
agree with similar reports which have established reduction in gastric 
motility as being the mechanism by which many antidiarrhoeal 
agents act[30]. 
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Comments 
Background
   From ancient times, about 10% of the adult population in the world 
suffer diabetes. Other important disease diarrhoeal is responsible 
for death of million of people each year. Plants are used as medicine 
from ancient times. At the present time studies on the medicinal 
activity of plants was intensified all over the world. The purpose 
of this work is to evaluate the pharmacological effects of ethanolic 
extracts of P. guajava leaves.
  
Research frontiers
   In the present research the authors performed the study of 
antidiabetic and antidiarrhoeal activities of ethanolic extracts of 
guava leaves, in vivo, on Wister rats. They demonstrated significant 
antidiabetic and antidiarrhoeal activities of the extracts that are the 
new contribution to the knowledge of guava biological activities.
Related reports
   There are many studies on different aspects of P. guajava biological 
activities but this paper is a new contribution to the antidiabetic and 
antidiarrhoeal activities of the ethanolic leaf extracts of the plant.
Innovations and breakthroughs
   The paper demonstrated the possible use of guava as antidiabetic 
and antidiarrhoeal with in vivo experiments. The methodology 
is modern and clearly applied to demonstrate the purposes of the 
research.
Applications
   As what was mentioned in the paper, the ethanolic leaf estracts can 
be use for the development of medicines.
Peer review
   This is a valuable research work in which the authors have 
demonstrated the antidiabetic and antidiarrhoeal activity in guava. 
The experimentation, in vivo, is correctly employed and with 
appropriate controls.
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